US Endoprosthesis Market

ID: MRFR/MED/12339-HCR
100 Pages
Vikita Thakur
Last Updated: April 06, 2026
US Endoprosthesis Market Research Report: By Product (Knee, Hip, Shoulder, Elbow, Finger/Hand, Ankle/Foot), By Knee (Primary, Partial, Revision Knee Replacement, Tumor, Custom Made), By Hip (Primary, Partial, Revision Hip Replacement, Tumor, Custom Made), By Shoulder (Primary, Revision Shoulder Replacement, Tumor, Custom Made) and By Elbow (Total Elbow, Radial Head Replacement, Tumor, Custom Made) - Growth & Industry Forecast 2025 To 2035
US Endoprosthesis Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)11.2%
2024 Market Size$ 2,787.12 Million
2025 Market Size$ 3,099.28 Million
2035 Market Size$ 8,961.85 Million
Key Players
Stryker Corporation
Zimmer Biomet Holdings Inc
DePuy Synthes
Medtronic plc
Smith & Nephew plc
Boston Scientific Corporation
Trends
  • Technological Advancements
  • Minimally Invasive Techniques
  • Regulatory Developments
Opportunities
  • Rising Geriatric Population
  • Increased Healthcare Expenditure
  • Growing Awareness of Joint Health
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Pharmaceutical, BY Product (USD Million)
      1. 4.1.1 Knee
      2. 4.1.2 Hip
      3. 4.1.3 Shoulder
      4. 4.1.4 Elbow
      5. 4.1.5 Finger/Hand
      6. 4.1.6 Ankle/Foot
    2. 4.2 Pharmaceutical, BY Knee (USD Million)
      1. 4.2.1 Primary
      2. 4.2.2 Partial
      3. 4.2.3 Revision Knee Replacement
      4. 4.2.4 Tumor
      5. 4.2.5 Custom Made
    3. 4.3 Pharmaceutical, BY Hip (USD Million)
      1. 4.3.1 Primary
      2. 4.3.2 Partial
      3. 4.3.3 Revision Hip Replacement
      4. 4.3.4 Tumor
      5. 4.3.5 Custom Made
    4. 4.4 Pharmaceutical, BY Shoulder (USD Million)
      1. 4.4.1 Primary
      2. 4.4.2 Revision Shoulder Replacement
      3. 4.4.3 Tumor
      4. 4.4.4 Custom Made
    5. 4.5 Pharmaceutical, BY Elbow (USD Million)
      1. 4.5.1 Total Elbow
      2. 4.5.2 Radial Head Replacement
      3. 4.5.3 Tumor
      4. 4.5.4 Custom Made
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Pharmaceutical
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Pharmaceutical
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Stryker Corporation (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Zimmer Biomet Holdings Inc (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 DePuy Synthes (US)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Medtronic plc (IE)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Smith & Nephew plc (GB)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Boston Scientific Corporation (US)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 NuVasive Inc (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Aesculap Implant Systems GmbH (DE)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 US MARKET ANALYSIS BY PRODUCT
    3. 6.3 US MARKET ANALYSIS BY KNEE
    4. 6.4 US MARKET ANALYSIS BY HIP
    5. 6.5 US MARKET ANALYSIS BY SHOULDER
    6. 6.6 US MARKET ANALYSIS BY ELBOW
    7. 6.7 KEY BUYING CRITERIA OF PHARMACEUTICAL
    8. 6.8 RESEARCH PROCESS OF MRFR
    9. 6.9 DRO ANALYSIS OF PHARMACEUTICAL
    10. 6.10 DRIVERS IMPACT ANALYSIS: PHARMACEUTICAL
    11. 6.11 RESTRAINTS IMPACT ANALYSIS: PHARMACEUTICAL
    12. 6.12 SUPPLY / VALUE CHAIN: PHARMACEUTICAL
    13. 6.13 PHARMACEUTICAL, BY PRODUCT, 2024 (% SHARE)
    14. 6.14 PHARMACEUTICAL, BY PRODUCT, 2024 TO 2035 (USD Million)
    15. 6.15 PHARMACEUTICAL, BY KNEE, 2024 (% SHARE)
    16. 6.16 PHARMACEUTICAL, BY KNEE, 2024 TO 2035 (USD Million)
    17. 6.17 PHARMACEUTICAL, BY HIP, 2024 (% SHARE)
    18. 6.18 PHARMACEUTICAL, BY HIP, 2024 TO 2035 (USD Million)
    19. 6.19 PHARMACEUTICAL, BY SHOULDER, 2024 (% SHARE)
    20. 6.20 PHARMACEUTICAL, BY SHOULDER, 2024 TO 2035 (USD Million)
    21. 6.21 PHARMACEUTICAL, BY ELBOW, 2024 (% SHARE)
    22. 6.22 PHARMACEUTICAL, BY ELBOW, 2024 TO 2035 (USD Million)
    23. 6.23 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY PRODUCT, 2025-2035 (USD Million)
      2. 7.2.2 BY KNEE, 2025-2035 (USD Million)
      3. 7.2.3 BY HIP, 2025-2035 (USD Million)
      4. 7.2.4 BY SHOULDER, 2025-2035 (USD Million)
      5. 7.2.5 BY ELBOW, 2025-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

US Endoprosthesis Market Segmentation

US Endoprosthesis Market By Product (USD Million, 2025-2035)

  • Knee
  • Hip
  • Shoulder
  • Elbow
  • Finger/Hand
  • Ankle/Foot

US Endoprosthesis Market By Knee (USD Million, 2025-2035)

  • Primary
  • Partial
  • Revision Knee Replacement
  • Tumor
  • Custom Made

US Endoprosthesis Market By Hip (USD Million, 2025-2035)

  • Primary
  • Partial
  • Revision Hip Replacement
  • Tumor
  • Custom Made

US Endoprosthesis Market By Shoulder (USD Million, 2025-2035)

  • Primary
  • Revision Shoulder Replacement
  • Tumor
  • Custom Made

US Endoprosthesis Market By Elbow (USD Million, 2025-2035)

  • Total Elbow
  • Radial Head Replacement
  • Tumor
  • Custom Made

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.